The occurrence of antibiotic resistance, ESBLs, MBL and NDM-1 in Uropathogenic Escherichia coli in Central part of Iran

Farshad Kakian, Javad Fathi, Fatemeh Alvandi, Mahnaz Moumivand, Abbas Rabei Gholami, Abolfazl Gholipour, Mohamad Hossein Rezaei, Behnam Zamanzad

Abstract


Broad-spectrum β-lactamase enzymes capable of destroying the antibiotics of β-lactam, cephalosporin, and Metallo-β-lactamase enzymes can also deactivate all β-lactams and carbapenems. This study aimed to determine ESBLs and MBLs enzymes and the frequency of NDM-1 gene­. In this study, 200 Escherichia coli isolates of women with urinary tract infection were collected (100 inpatients and 100 outpatients). Minimum inhibitory concentration (MIC) for ceftazidime and meropenem was determined by E-test. A phenotypic confirmation test was used to detect ESBL enzymes. MBLs production was performed with modified Hodge test (MHT) and EDTA disk synergy (EDS) test. PCR was used for detecting the presence of NDM-1 gene. From 200 isolates, 93 isolates produce ESBL enzymes. Overall, 97 isolates were resistant to ceftazidime, and 38 isolates resistant to meropenem. The results of the MHT and EDS positive tests were 41 and 16 isolates, respectively. NDM-1 was not found in any of the patients. The prevalence of E. coli isolates producing both ESBLs and MBLs enzymes, is a serious threat to clinical infections. Accordingly, for the control and treatment of these strains, rapid and accurate identification can be greatly helpful.


Keywords


Escherichia coli; MIC; ESBL; NDM-1

References


Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015; 13(5):269-84.

Kakian F, Zamanzad B, Gholipour A, Zamanzad K. Determination of the carbapenem resistance in Escherichia coli isolated from samples obtained from Shahrekord hospitals and determination of their minimum inhibitory concentration. J Shahrekord Univ Med Sci. 2019; 21(6):280-3.

Sedighimehr N, Dehghan Manshadi F. Electrical Stimulation for Lower Urinary Tract Dysfunction in People with Multiple Sclerosis: A Systematic Review. J Clin Physiother Res. 2018; 3(2):48-53.

Nickel JC. Inflammation and benign prostatic hyperplasia. Urol Clin North Am. 2008; 35(1):109-15; vii.

Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect. 2007; 55(3):254-9.

Jamborova I, Dolejska M, Vojtech J, Guenther S, Uricariu R, Drozdowska J, et al. Plasmid-mediated resistance to cephalosporins and fluoroquinolones in various Escherichia coli sequence types isolated from rooks wintering in Europe. Appl Environ Microbiol. 2015; 81(2):648-57.

Evans BA, Amyes SG. OXA β-lactamases. Clin Microbiol Rev. 2014; 27(2):241-63.

Kakian F, Shahini Shams Abadi M, Zamanzad B, Najafi H, Amiri M, Gholipour A. Frequency Assessment of OXA-10 and PER β-Lactamase Genes and Determination of Minimum Inhibitory Concentration in Klebsiella Strains Isolated from Urinary Tract Infections. Jundishapur J Microbiol. 2019; 12(2):e65500.

Hawkey PM, Livermore DM. Carbapenem antibiotics for serious infections. Bmj. 2012; 344:e3236.

Lee CH, Su LH, Tang YF, Liu JW. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates. J Antimicrob Chemother. 2006; 58(5):1074-7.

Hashemi B, Afkhami H, Khaledi M, Kiani M, Bialvaei AZ, Fathi J, et al. Frequency of Metalo beta Lactamase genes, bla IMP1, INT 1 in Acinetobacter baumanii isolated from burn patients North of Iran. Gene Rep. 2020; 21:100800.

Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol. 2012; 50(12):3877-80.

Chika E, Malachy U, Ifeanyichukwu I, Peter E, Thaddeus G, Charles E. Phenotypic detection of metallo-β-lactamase (MBL) enzyme in Enugu, Southeast Nigeria. Am J Biol Chem Pharm Sci. 2014; 2(2):1-6.

Bocanegra-Ibarias P, Garza-González E, Morfín-Otero R, Barrios H, Villarreal-Treviño L, Rodríguez-Noriega E, et al. Molecular and microbiological report of a hospital outbreak of NDM-1-carrying Enterobacteriaceae in Mexico. PLoS One. 2017; 12(6):e0179651.

Poirel L, Lagrutta E, Taylor P, Pham J, Nordmann P. Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother. 2010; 54(11):4914-6.

Nordmann P, Boulanger AE, Poirel L. NDM-4 metallo-β-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob Agents Chemother. 2012; 56(4):2184-6.

Amjad A, Mirza I, Abbasi S, Farwa U, Malik N, Zia F. Modified Hodge test: A simple and effective test for detection of carbapenemase production. Iran J Microbiol. 2011; 3(4):189-93.

Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2001; 7(2):88-91.

Damavandi MS, Gholipour A, Latif Pour M. Prevalence of Class D Carbapenemases among Extended-Spectrum β-Lactamases Producing Escherichia coli Isolates from Educational Hospitals in Shahrekord. J Clin Diagn Res. 2016; 10(5):Dc01-5.

Nordmann P, Poirel L, Carrër A, Toleman MA, Walsh TR. How to detect NDM-1 producers. J Clin Microbiol. 2011; 49(2):718-21.

Qi C, Malczynski M, Parker M, Scheetz MH. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J Clin Microbiol. 2008; 46(3):1106-9.

Kaesbohrer A, Schroeter A, Tenhagen BA, Alt K, Guerra B, Appel B. Emerging antimicrobial resistance in commensal Escherichia coli with public health relevance. Zoonoses Public Health. 2012; 59 Suppl 2:158-65.

Sanz-García M, Fernández-Cruz A, Rodríguez-Créixems M, Cercenado E, Marin M, Muñoz P, et al. Recurrent Escherichia coli bloodstream infections: epidemiology and risk factors. Medicine (Baltimore). 2009; 88(2):77-82.

Fathi J, Ebrahimi F, Nazarian S, Tarverdizade Y. Purification of Shiga-like Toxin from Escherichia coli O157: H7 by a Simple Method. J Appl Biotechnol Rep. 2017; 4(4):707-11.

Rahamathulla M, Harish B, Mataseje L, Mulvey M. Carbapenem resistance mechanisms among blood isolates of Klebsiella pneumoniae and Escherichia coli. Afr J Microbiol Res. 2016; 10(2):45-53.

Teethaisong Y, Eumkeb G, Chumnarnsilpa S, Autarkool N, Hobson J, Nakouti I, et al. Phenotypic detection of AmpC β-lactamases, extended-spectrum β-lactamases and metallo-β-lactamases in Enterobacteriaceae using a resazurin microtitre assay with inhibitor-based methods. J Med Microbiol. 2016; 65(10):1079-87.

Ullah F, Malik SA, Ahmed J. Antibiotic susceptibility pattern and ESBL prevalence in nosocomial Escherichia coli from urinary tract infections in Pakistan. Afr J Biotechnol. 2009; 8:3921-6.

Singh N, Pattnaik D, Neogi DK, Jena J, Mallick B. Prevalence of ESBL in Escherichia coli Isolates Among ICU Patients in a Tertiary Care Hospital. J Clin Diagn Res. 2016; 10(9):Dc19-dc22.

Jamil J, Haroon M, Sultan A, Khan MA, Gul N. Prevalence, antibiotic sensitivity and phenotypic screening of ESBL/MBL producer E. coli strains isolated from urine; District Swabi, KP, Pakistan. J Pak Med Assoc. 2018; 68(11):1704-7.

Qamar MU, Mustafa G, Qaisar U, Azeem F, Shahid M, Manzoor I, et al. Molecular detection of blaNDM and blaVIM in clinically isolated multi-drug resistant Escherichia coli in Pakistan. Pak J Pharm Sci. 2019; 32(S5):2305-9.

Koraei M, Moosavian M, Saki M. Investigation of New Delhi Metallo-Beta-Lactamase 1 (NDM-1) in Clinical Enterobacteriaceae Isolates in Southwest Iran. J Res Med Dent Sci. 2018; 6:1-5.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.